Huntsman Completes Amines Expansion in Llanelli, Wales

The Performance Products division of Huntsman Corporation today announced that it has completed the expansion of its specialty amines manufacturing facility in Llanelli Wales. This expansion has increased capacity by more than 50%, primarily for Jeffamine polyetheramines, DiglycolamineAgent and morpholine.

Apart from Llanelli, Huntsman also supplies these products from the United States (Port Neches and Conroe both in Texas) and Singapore (Jurong), with previously announced plans to build a plant in Saudi Arabia (Jubail).

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.